As previously reported for RECQ1 helicase [25], we also identified that high expression of BLM is associated with a poor outcome in newly diagnosed MM patients treated by high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) (p = 0.003) (Supplementary Fig. S7A). This evidence concerns the gene BLM and Miyoshi myopathy.